Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
A Phase 2 Study of MEDI4736 (Durvalumab) and Tremelimumab Alone or in Combination With High or Low-Dose Radiation in Metastatic Colorectal and NSCLC
Sponsor: National Cancer Institute (NCI)
A PHASE2 clinical study on Metastatic Colorectal Carcinoma and Metastatic Lung Non-Small Cell Carcinoma, this trial is ongoing. The trial is conducted by National Cancer Institute (NCI) and has accumulated 58 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
58 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE2
-
Sep 2025 — Mar 2026 [monthly]
Active Not Recruiting PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Mar 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE2
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE2
▶ Show 53 earlier versions
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Jan 2024 — Feb 2024 [monthly]
Active Not Recruiting PHASE2
-
Dec 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE2
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE2
-
Jun 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE2
-
Apr 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE2
-
Feb 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
-
Dec 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
May 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE2
-
Feb 2022 — May 2022 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE2
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE2
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE2
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE2
-
Jul 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE2
-
May 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE2
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE2
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Sep 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE2
-
Dec 2017 — Feb 2018 [monthly]
Recruiting PHASE2
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE2
-
Sep 2017 — Oct 2017 [monthly]
Recruiting PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE2
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Atlanta, United States , Baltimore, United States , Boston, United States , Chapel Hill, United States , Charlottesville, United States , City of Saint Peters, United States , Cleveland, United States , Columbus, United States , Creve Coeur, United States , Detroit, United States and 23 more locations